3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Pathologic Processes
1
Neoplastic Processes
1
Neoplasms
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
288
Capecitabine
218
Fluorouracil
212
Irinotecan
145
Leucovorin
139
Gemcitabine
125
S 1 (combination)
110
apatinib
109
Cisplatin
102
Drug Therapy
98
Radiotherapy
97
Paclitaxel
97
Bevacizumab
97
camrelizumab
89
sintilimab
79
Cetuximab
75
lenvatinib
62
Neoadjuvant Therapy
61
tislelizumab
55
Surgical Procedures, Operative
54
toripalimab
53
Sorafenib
53
Folfox protocol
53
Docetaxel
52
130-nm albumin-bound paclitaxel
47
Laparoscopy
41
HMPL-013
40
XELOX
39
Radiosurgery
36
Albumin-Bound Paclitaxel
36
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Electrochemotherapy
×
Gastrointestinal
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled